EMA Reports Progress with EU Clinical Trial & Orphan IT Systems
The European Medicines Agency says progress is being made with new IT systems for clinical trial and orphan designation applications in the EU.
You may also be interested in...
Revisions and restructuring of the contract with the developers mean that Europe’s new clinical trials system will not go live next year as planned, although the European Medicines Agency says progress has been made with development of the system.
The new portal is expected to provide an improved method for applying for and managing EU orphan drug designations.